Risa M Hoffman1, Crispin Moyo2, Kelvin T Balakasi3, Zumbe Siwale2, Julie Hubbard4, Ashley Bardon5, Matthew P Fox6, Gift Kakwesa3, Thokozani Kalua7, Mwiza Nyasa-Haambokoma2, Kathryn Dovel4, Paula M Campbell4, Chi-Hong Tseng4, Pedro T Pisa8, Refiloe Cele9, Sundeep Gupta4, Mariet Benade10, Lawrence Long11, Thembi Xulu12, Ian Sanne12, Sydney Rosen11. 1. Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA. Electronic address: rhoffman@mednet.ucla.edu. 2. Right to Care Zambia, Lusaka, Zambia. 3. Partners in Hope, Lilongwe, Malawi. 4. Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA. 5. Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA. 6. Department of Epidemiology, School of Public Health, Boston University, Boston, MA, USA; Department of Global Health, School of Public Health, Boston University, Boston, MA, USA; Department of Paediatrics, University of the Witwatersrand, Johannesburg, South Africa. 7. Department of HIV and AIDS, Malawi Ministry of Health, Lilongwe, Malawi. 8. Department of Paediatrics, University of the Witwatersrand, Johannesburg, South Africa; Right to Care South Africa, Centurion, South Africa. 9. Department of Paediatrics, University of the Witwatersrand, Johannesburg, South Africa. 10. Department of Global Health, School of Public Health, Boston University, Boston, MA, USA. 11. Department of Global Health, School of Public Health, Boston University, Boston, MA, USA; Department of Paediatrics, University of the Witwatersrand, Johannesburg, South Africa. 12. Right to Care South Africa, Centurion, South Africa.
Abstract
BACKGROUND:Facility-based, multimonth dispensing of antiretroviral therapy (ART) for HIV could reduce burdens on patients and providers and improve retention in care. We assessed whether 6-monthly ART dispensing was non-inferior to standard of care and 3-monthly ART dispensing. METHODS: We did a pragmatic, cluster-randomised, unblinded, non-inferiority trial (INTERVAL) at 30 health facilities in Malawi and Zambia. Eligible participants were aged 18 years or older, HIV-positive, and were clinically stable on ART. Before randomisation, health facilities (clusters) were matched on the basis of country, ART cohort size, facility type (ie, hospital vs health centre), and region or province. Matched clusters were randomly allocated (1:1:1) to standard of care, 3-monthly ART dispensing, or 6-monthly ART dispensing using a simple random allocation sequence. The primary outcome was retention in care at 12 months, defined as the proportion of patients with less than 60 consecutive days without ART during study follow-up, analysed by intention to treat. A 2·5% margin was used to assess non-inferiority. This study is registered with ClinicalTrials.gov, NCT03101592. FINDINGS:Between May 15, 2017, and April 30, 2018, 9118 participants were randomly assigned, of whom 8719 participants (n=3012, standard of care group; n=2726, 3-monthly ART dispensing group; n=2981, 6-monthly ART dispensing group) had primary outcome data available at 12 months and were included in the primary analysis. The median age of participants was 42·7 years (IQR 36·1-49·9) and 5774 (66·2%) of 8719 were women. The primary outcome was met by 2478 (82·3%) of 3012 participants in the standard of care group, 2356 (86·4%) of 2726 participants in the 3-monthly ART dispensing group, and 2729 (91·5%) of 2981 participants in the 6-monthly ART dispensing group. After adjusting for clustering, for retention in care at 12 months, the 6-monthly ART dispensing group was non-inferior to the standard of care group (percentage-point increase 9·1 [95% CI 0·9-17·2]) and to the 3-monthly ART dispensing group (5·0% [1·0-9·1]). INTERPRETATION: Clinical visits with ART dispensing every 6 months was non-inferior to standard of care and 3-monthly ART dispensing. 6-monthly ART dispensing is a promising strategy for the expansion of ART provision and achievement of HIV treatment targets in resource-constrained settings. FUNDING: US Agency for International Development.
RCT Entities:
BACKGROUND: Facility-based, multimonth dispensing of antiretroviral therapy (ART) for HIV could reduce burdens on patients and providers and improve retention in care. We assessed whether 6-monthly ART dispensing was non-inferior to standard of care and 3-monthly ART dispensing. METHODS: We did a pragmatic, cluster-randomised, unblinded, non-inferiority trial (INTERVAL) at 30 health facilities in Malawi and Zambia. Eligible participants were aged 18 years or older, HIV-positive, and were clinically stable on ART. Before randomisation, health facilities (clusters) were matched on the basis of country, ART cohort size, facility type (ie, hospital vs health centre), and region or province. Matched clusters were randomly allocated (1:1:1) to standard of care, 3-monthly ART dispensing, or 6-monthly ART dispensing using a simple random allocation sequence. The primary outcome was retention in care at 12 months, defined as the proportion of patients with less than 60 consecutive days without ART during study follow-up, analysed by intention to treat. A 2·5% margin was used to assess non-inferiority. This study is registered with ClinicalTrials.gov, NCT03101592. FINDINGS: Between May 15, 2017, and April 30, 2018, 9118 participants were randomly assigned, of whom 8719 participants (n=3012, standard of care group; n=2726, 3-monthly ART dispensing group; n=2981, 6-monthly ART dispensing group) had primary outcome data available at 12 months and were included in the primary analysis. The median age of participants was 42·7 years (IQR 36·1-49·9) and 5774 (66·2%) of 8719 were women. The primary outcome was met by 2478 (82·3%) of 3012 participants in the standard of care group, 2356 (86·4%) of 2726 participants in the 3-monthly ART dispensing group, and 2729 (91·5%) of 2981 participants in the 6-monthly ART dispensing group. After adjusting for clustering, for retention in care at 12 months, the 6-monthly ART dispensing group was non-inferior to the standard of care group (percentage-point increase 9·1 [95% CI 0·9-17·2]) and to the 3-monthly ART dispensing group (5·0% [1·0-9·1]). INTERPRETATION: Clinical visits with ART dispensing every 6 months was non-inferior to standard of care and 3-monthly ART dispensing. 6-monthly ART dispensing is a promising strategy for the expansion of ART provision and achievement of HIV treatment targets in resource-constrained settings. FUNDING: US Agency for International Development.
Authors: Youngji Jo; Sydney Rosen; Karla Therese L Sy; Bevis Phiri; Amy N Huber; Muya Mwansa; Hilda Shakwelele; Prudence Haimbe; Mpande M Mwenechanya; Priscilla Lumano-Mulenga; Brooke E Nichols Journal: J Int AIDS Soc Date: 2021-10 Impact factor: 5.396
Authors: Isaac Derickk Kimera; Christabellah Namugenyi; Jeremy I Schwartz; Douglas Joseph Musimbaggo; Rebecca Ssenyonjo; Praise Atukunda; Gerald Mutungi; Frank Mugabe; Fortunate Ambangira; Mary Mbuliro; Rodgers Katwesigye; Dinesh Neupane; Isaac Ssinabulya; Fred Collins Semitala; Christian Delles; Martin Muddu Journal: J Hum Hypertens Date: 2022-03-04 Impact factor: 3.012
Authors: Mohammed Limbada; David Macleod; Vasty Situmbeko; Ellen Muhau; Osborn Shibwela; Bwalya Chiti; Sian Floyd; Albertus J Schaap; Richard Hayes; Sarah Fidler; Helen Ayles Journal: Lancet HIV Date: 2021-11-26 Impact factor: 16.070
Authors: Noelle Le Tourneau; Ashley Germann; Ryan R Thompson; Nathan Ford; Sheree Schwartz; Laura Beres; Aaloke Mody; Stefan Baral; Elvin H Geng; Ingrid Eshun-Wilson Journal: PLoS Med Date: 2022-03-22 Impact factor: 11.069